Blood Management Program in the Post - Operative Period.
NCT ID: NCT02149069
Last Updated: 2015-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2014-11-30
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients
NCT01820949
Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery
NCT02311309
Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management
NCT01686659
Trauma Associated Bleeding: Effectiveness of an Early Coagulation Support Protocol
NCT03354559
Stored RBC Transfusion and Immonomodulation
NCT01976234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The implementation of this process should improve transfusion therapy in the peri-operative period in order to:
* correct the transfusional approach to surgical patients
* optimize the management of transfusional resources (red blood cells, plasma, platelets)
* optimize the management of plasma derivatives, drugs and techniques designed to limit the use of homologous blood
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda USL Reggio Emilia - IRCCS
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PAMELABERNI
Data Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erminia Di Bartolomeo, MD
Role: PRINCIPAL_INVESTIGATOR
ASMN-IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS-Arcispedale Santa Maria Nuova
Reggio Emilia, Emilia-Romagna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BMP - TRASFU1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.